Prognostic value of combined nutritional and inflammatory markers in NSCLC patients receiving ICIs
The combined NRS 2002 and NLR scoring can serve as an effective prognostic tool for NSCLC patients receiving ICIs treatment. This scoring system helps clinicians more accurately identify patients who will benefit from immunotherapy, thereby facilitating more personalized treatment plans. Further validation of this scoring system's applicability and reliability is warranted in future multicenter, large-sample prospective studies.
Authors
- Xuefeng Lu (ORCID: https://orcid.org/0000-0001-7647-1317)
- Zhisheng Chen (ORCID: https://orcid.org/0000-0002-0854-2547)
- Haiyan Chen (ORCID: https://orcid.org/0009-0000-6926-6390)
- Jiaxin Liu (ORCID: https://orcid.org/0009-0006-5232-3997)
- Qingwei Zhang (ORCID: https://orcid.org/0009-0003-0567-6739)
- Peihong Zhang
- Jianying Liu (ORCID: https://orcid.org/0009-0006-2040-1188)
- Yijiao Xu (ORCID: https://orcid.org/0000-0002-4685-2378)
Institutions
- Fudan University (CN)
- Zhongshan Hospital of Xiamen University (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1007/s12672-025-02391-9
- Citations
- 3
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Natural Science Foundation of Fujian Province